Physician profile
Johnathan Salvi
NPI 1134874589
$13,690.24
in general payments reported to CMS, 2019-2025
38 companies · $4,180 in 2025
The $4,180 reported for 2025 was more than what 98% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,044 · 2023: $3,217 · 2024: $4,249 · 2025: $4,180.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Education: $24.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,621.65 |
| Education | $24.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,431.84 | 2022-2025 | Jardiance, Ofev, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $1,356.66 | 2022-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $1,345.67 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $1,076.69 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Pfizer INC. | $956.08 | 2022-2025 | |
| Abbvie INC. | $881.62 | 2022-2025 | |
| Glaxosmithkline, LLC. | $707.87 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Axsome Therapeutics, INC. | $666.73 | 2022-2025 | Auvelity, Sunosi |
| Amgen INC. | $648.78 | 2022-2025 | Repatha, Otezla, Prolia |
| Lundbeck LLC | $443.21 | 2022-2025 | Rexulti |
| Corcept Therapeutics | $436.95 | 2024-2025 | Korlym |
| Otsuka America Pharmaceutical, INC. | $383.29 | 2024-2025 | Rexulti |
| Paratek Pharmaceuticals, INC. | $359.54 | 2023-2025 | Nuzyra, Xhance |
| Idorsia Pharmaceuticals US INC | $349.76 | 2022-2024 | Quviviq |
| Janssen Pharmaceuticals, INC | $325.14 | 2022-2025 | Spravato, Xarelto |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Salvi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.